Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-γ and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome

Clinical Immunology

Volumn 131, Issue 2, 2009, Pages 333-342

  Liu, Xiaoli ^a   Yang, Peizeng ^b   Lin, Xiaomin ^a   Ren, Xiangrong ^a   Zhou, Hongyan ^a   Huang, Xiangkun ^a   Chi, Wei ^a   Kijlstra, Aize ^c,d   Chen, Ling ^e  

^a SUN YAT SEN UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d WAGENINGEN UNIVERSITY   (Netherlands)

^e JULES STEIN EYE INSTITUTE   (United States)

Author keywords

Cyclosporin A; IFN ; IL 17; Vogt Koyanagi Harada syndrome

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 17; IONOMYCIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PREDNISONE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TREATMENT OUTCOME; UVEITIS; VISION; VISUAL ACUITY; VOGT KOYANAGI SYNDROME;

ADRENAL CORTEX HORMONES; CYCLOSPORINE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; RNA, MESSENGER; T-LYMPHOCYTES; TH1 CELLS; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 64149116428     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.12.007     Document Type: Article

References (36)

1. Yang P., Zhang Z., Zhou H., Li B., Huang X., Gao Y., Zhu L., Ren Y., Klooster J., and Kijlstra A. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr. Eye Res. 30 (2005) 943-948
2. Yang P., Ren Y., Li B., Fang W., Meng Q., and Kijlstra A. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology 114 (2007) 606-614
3. Murakami S., Inaba Y., Mochizuki M., Nakajima A., and Urayama A. A nation-wide survey on the occurrence of Vogt-Koyanagi-Harada disease in Japan. Nippon Ganka Gakkai Zasshi 98 (1994) 389-392
4. Rubsamen P.E., and Gass J.D. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch. Ophthalmol. 109 (1991) 682-687
5. Gocho K., Kondo I., and Yamaki K. Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease. Invest. Ophthalmol. Vis. Sci. 42 (2001) 2004-2009
6. + T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest. Ophthalmol. Vis. Sci. 47 (2006) 2547-2554
7. Imai Y., Sugita M., Nakamura S., Toriyama S., and Ohno S. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease. Curr. Eye Res. 22 (2001) 312-318
8. Amadi-Obi A., Yu C.R., Liu X., Mahdi R.M., Clarke G.L., Nussenblatt R.B., Gery I., Lee Y.S., and Egwuagu C.E. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13 (2007) 711-718
9. Banerjee S., Savant V., Scott R.A., Curnow S.J., Wallace G.R., and Murray P.I. Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Invest. Ophthalmol. Vis. Sci. 48 (2007) 2203-2207
10. + T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J. Allergy Clin. Immunol. 119 (2007) 1218-1224
11. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., and Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100 (2000) 655-669
12. Li B., Yang P., Zhou H., Huang X., Jin H., Chu L., Gao Y., Zhu L., and Kijlstra A. Upregulation of T-bet expression in peripheral blood mononuclear cells during Vogt-Koyanagi-Harada disease. Br. J. Ophthalmol. 89 (2005) 1410-1412
13. Read R.W., Yu F., Accorinti M., Bodaghi B., Chee S.P., Fardeau C., Goto H., Holland G.N., Kawashima H., Kojima E., Lehoang P., Lemaitre C., Okada A.A., Pivetti-Pezzi P., Secchi A., See R.F., Tabbara K.F., Usui M., and Rao N.A. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am. J. Ophthalmol. 142 (2006) 119-124
14. Vitale A.T., Rodriguez A., and Foster C.S. Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis. Ophthalmology 103 (1996) 365-373 discussion 373-4
15. Nussenblatt R.B., Palestine A.G., Chan C.C., Stevens Jr. G., Mellow S.D., and Green S.B. Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis. Am. J. Ophthalmol. 112 (1991) 138-146
16. Frassanito M.A., Dammacco R., Fusaro T., Cusmai A., Guerriero S., and Sborgia C. Combined cyclosporin-A/prednisone therapy of patients with active uveitis suppresses IFN-gamma production and the function of dendritic cells. Clin. Exp. Immunol. 133 (2003) 233-239
17. De A., Blotta H.M., Mamoni R.L., Louzada P., Bertolo M.B., Foss N.T., Moreira A.C., and Castro M. Effects of dexamethasone on lymphocyte proliferation and cytokine production in rheumatoid arthritis. J. Rheumatol. 29 (2002) 46-51
18. Read R.W., Holland G.N., Rao N.A., Tabbara K.F., Ohno S., Arellanes-Garcia L., Pivetti-Pezzi P., Tessler H.H., and Usui M. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am. J. Ophthalmol. 131 (2001) 647-652
19. Hogan M.J., Kimura S.J., and Thygeson P. Signs and symptoms of uveitis. I. Anterior uveitis. Am. J. Ophthalmol. 47 (1959) 155-170
20. Kimura S.J., Thygeson P., and Hogan M.J. Signs and symptoms of uveitis. II. Classification of the posterior manifestations of uveitis. Am. J. Ophthalmol. 47 (1959) 171-176
21. Egwuagu C.E., Sztein J., Mahdi R.M., Li W., Chao-Chan C., Smith J.A., Charukamnoetkanok P., and Chepelinsky A.B. IFN-gamma increases the severity and accelerates the onset of experimental autoimmune uveitis in transgenic rats. J. Immunol. 162 (1999) 510-517
22. Akahoshi M., Nakashima H., Tanaka Y., Kohsaka T., Nagano S., Ohgami E., Arinobu Y., Yamaoka K., Niiro H., Shinozaki M., Hirakata H., Horiuchi T., Otsuka T., and Niho Y. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum. 42 (1999) 1644-1648
23. Kurasawa K., Hirose K., Sano H., Endo H., Shinkai H., Nawata Y., Takabayashi K., and Iwamoto I. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum. 43 (2000) 2455-2463
24. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., Bamba T., and Fujiyama Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52 (2003) 65-70
25. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., and Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201 (2005) 233-240
26. Tzartos J.S., Friese M.A., Craner M.J., Palace J., Newcombe J., Esiri M.M., and Fugger L. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172 (2008) 146-155
27. Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., Giuliani F., Arbour N., Becher B., and Prat A. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13 (2007) 1173-1175
28. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., Saito S., Inoue K., Kamatani N., Gillespie M.T., Martin T.J., and Suda T. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103 (1999) 1345-1352
29. + T helper cells. Cell 126 (2006) 1121-1133
30. Yao Z., Painter S.L., Fanslow W.C., Ulrich D., Macduff B.M., Spriggs M.K., and Armitage R.J. Human IL-17: a novel cytokine derived from T cells. J. Immunol. 155 (1995) 5483-5486
31. Reem G.H., Cook L.A., and Palladino M.A. Regulation of interleukin-2 synthesis in human thymocytes. J. Biol. Response Mod. 3 (1984) 195-205
32. Drosos A.A., Voulgari P.V., Papadopoulos I.A., Politi E.N., Georgiou P.E., and Zikou A.K. Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study. Clin. Exp. Rheumatol. 16 (1998) 695-701
33. Ziolkowska M., Koc A., Luszczykiewicz G., Ksiezopolska-Pietrzak K., Klimczak E., Chwalinska-Sadowska H., and Maslinski W. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 164 (2000) 2832-2838
34. Briggs W.A., Gao Z.H., Xing J.J., Scheel P.J., Gimenez L.F., Choi M.J., and Burdick J.F. Differential suppression of dialysis patients' lymphocyte IFN-gamma production by glucocorticoids and cyclosporine. Cytokine 8 (1996) 804-808
35. Woltman A.M., de Fijter J.W., Kamerling S.W., Paul L.C., Daha M.R., and van Kooten C. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur. J. Immunol. 30 (2000) 1807-1812
36. + T cells via down-regulation of PI3K/Akt and NF-kappaB. Immunol. Lett. 108 (2007) 88-96